The impact of fecal microbiota transplantation on refractory ulcerative colitis: A systematic review and Meta-Analysis of randomised controlled trials
FMT does not significantly improve clinical or endoscopic remission in refractory UC, suggesting limited efficacy in this population despite a favorable safety profile. Larger, standardized trials are warranted.
Authors
- Valentine C. Nriagu (ORCID: https://orcid.org/0000-0003-1957-8745)
- M.L. Williams (ORCID: https://orcid.org/0000-0002-9483-3008)
- Maher Taha (ORCID: https://orcid.org/0009-0005-7051-2348)
- Sarpong Boateng (ORCID: https://orcid.org/0000-0003-0199-0424)
- Chimezirim Ezeano (ORCID: https://orcid.org/0009-0000-0524-0685)
- Chike B Onyali (ORCID: https://orcid.org/0009-0001-1913-9905)
- Augustina Annan
- Olanrewaju Adeniran (ORCID: https://orcid.org/0000-0002-2870-4873)
- Chidi Arthur Igbo
Institutions
- West Virginia University (US)
- Yale New Haven Hospital (US)
- Maimonides Medical Center (US)
- Bridgeport Hospital (US)
- Jersey City Medical Center (US)
- Texas Health Resources Foundation (US)
- University of Nigeria Teaching Hospital (NG)
- Bradford Teaching Hospitals NHS Foundation Trust (GB)
- West Virginia State University (US)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1186/s12876-025-04185-3
- Citations
- 1
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 1.40